Omeros | OMER - Ingresos Por Ventas





Ventas Cambio Fecha
Adma Biologics USD 114.5M 24.66M 2026-03
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Cytokinetics USD 28.6M 9.25M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 425.49M 119.53M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Pacira USD 192.4M 15.4M 2026-06
Pfizer USD 15.03B 530M 2026-06
Rockwell Medical USD 25.83M 3.15M 2024-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06